This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background The significance of stress-test induced arrhythmias has been examined in prior studies, but there is no clear consensus regarding its significance. Objectives To determine the significance of stress test-induced arrhythmias. Atrialarrhythmia during stress testing, on the other hand, shows no association with mortality.
Introduction Atrialfibrillation is the most prevalent sustained arrhythmia worldwide and is expected to increase substantially within the coming years. Eligible patients are randomised 1:1 to either a combined supervised and eHealth-based exercise intervention or usual care for 12 months.
tim.hodson Thu, 04/24/2025 - 10:37 April 23, 2025 The Heart Rhythm Society (HRS) has released a framework outlining criteria for establishing an AtrialFibrillation (AF) Center of Excellence (CoE) and key operational standards to provide multidisciplinary care for AF patients. million adults. 2024; 84(16): 1501-8.
Atrialfibrillation is the most prevalent arrhythmia with a lifetime risk of nearly 30%. It can be associated with reduced quality of life and complications such as heart failure and stroke. Pulmonary vein isolation (PVI) is the most effective treatment for rhythm control.
Patients with a common heart arrhythmia called AtrialFibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, according to a new article.
In adults with congenital heart disease (ACHD patients), atrialarrhythmias (AA) and heart failure (HF) are common. Early diagnosis and ECG documentation is therefore essential for arrhythmia management. Of these, AA is one of the leading causes for hospital admissions in ACHD care.
Nature Reviews Cardiology, Published online: 28 February 2024; doi:10.1038/s41569-024-01004-2 Atrialfibrillation is the most common sustained arrhythmia and imposes a substantial burden on patients and health-care providers.
Atrialfibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. Researchers have recently developed a deep-learning model capable of predicting the transition from a normal cardiac rhythm to atrialfibrillation.
BackgroundInstant atrialfibrillation termination (AFT) during radiofrequency ablation has been suggested as a predictor of prognosis in persistent atrialfibrillation (AF). The baseline conditions were similar, except that patients with AFT presented significantly lower left atrial diameter (LAD).
(MedPage Today) -- For patients undergoing catheter ablation for atrialfibrillation (Afib), there was no signal that a brief course of colchicine reduced atrialarrhythmia recurrence or improved clinical outcomes when taken for 10 days starting.
BackgroundAtrial fibrillation (AF) is a common arrhythmia associated with an increased risk of stroke, heart failure, and mortality. Immune infiltration plays a crucial role in AF pathogenesis, yet its mechanisms remain unclear.
Based on continuous monitoring of early recurrence of atrial tachyarrhythmia immediately after patients have undergone atrialfibrillation ablation, Musat et al. However, this reasoning disregards valuable data regarding early arrhythmia recurrences and their potential significance.
Atrialfibrillation, or AFib, is a fast and irregular heart rhythm that, left untreated, can lead to blood clots, stroke and heart failure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.
Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent.
ABSTRACT Background Sotalol is used for the maintenance of sinus rhythm among patients with atrialfibrillation. Methods In the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry, we analyzed outcomes among patients undergoing elective IV sotalol load for atrialarrhythmias (AT/AF).
Primary endpoint was the incidence of patients with new onset supraventricular arrhythmia (AF, atrial flutter or any supraventricular tachycardia) lasting >30s, post PFO closure.ResultsA total of 59 patients met the inclusion criteria. A total of 88 supraventricular arrhythmia events (96.6% days (IQR 1321). days (IQR 1321).
IntroductionAtrial fibrillation (AF) is a prevalent cardiac arrhythmia and a significant contributor to cardioembolic stroke, a condition closely linked to cognitive decline. However, research reveals that AF itself is independently associated with an increased risk of cognitive impairment.
A new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrialfibrillation, the most common type of abnormal heart rhythm.
(MedPage Today) -- BOSTON -- For persistent atrialfibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after one procedure regardless of antiarrhythmic.
BackgroundAtrial fibrillation (AF) is the most common arrhythmia worldwide. Data regarding AF screening in conflict countries emergency departments (ED) is lacking.MethodsWe included consecutive patients >40 years old who reported to the ED of a Syrian tertiary centre between July 2024 and September 2024.
BackgroundAtrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide, posing significant health burdens. Pulsed field ablation (PFA) is an emerging non-thermal technique that is gaining traction due to the ability to selectively target myocardial cells and minimize damage to surrounding tissues.
When atrialfibrillation (AF) begins, it can start with a single focus, degenerating to multiple wavelets, and it spreads throughout the entire surface area of both atria. A fibrillatory wave that occurs at a rate of more than 600 beats per minute can cause fatigue in the long run, leading to atrial dilation.
Specific cardiovascular diseases, such as acute myocardial infarction, arrhythmias, pulmonary hypertension and pericarditis, were also pointed. Elevated risk of arrhythmias, particularly atrialfibrillation, correlated with occupational silica exposure.
ABSTRACT Introduction In atrialfibrillation (AF) ablation procedures, the CARTO VIZIGO Bidirectional Guiding Sheath has previously shown promising results in reducing fluoroscopy times without compromising clinical effectiveness or safety compared with non-steerable sheaths. Results Of 199 patients included (mean age, 69.7
Recent research has also found the incidence of atrialfibrillation (AFib), the most common type of irregular heart rhythm or arrhythmia, continues to rise, according to the study. Binge drinking (five drinks within two hours for men and four drinks within two hours for women) is common around the world.
Introduction Catheter ablation is an effective and safe strategy for treating atrialfibrillation patients. Method Patient baseline characteristics and electrophysiological parameters were examined to identify the predictors of atrialfibrillation recurrence following catheter ablation. years following catheter ablation.
Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureAtrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally.
Atrialfibrillation (AF) is a relatively prevalent arrhythmia in patients with kidney failure requiring dialysis, who face a high risk of stroke and bleeding, and anticoagulation is a challenging decision.
Current guideline indications for intervention in asymptomatic patient are centred on left ventricular dimensions and ejection fraction and may include consideration in atrialfibrillation, pulmonary hypertension and those with left atrial dilatation.
Cardiomyopathy (CM) is associated with arrhythmias, resulting in considerable morbidity and mortality. Atrialfibrillation (AF) is a common arrhythmia linked to adverse outcomes, yet mortality trends between AF and other arrhythmias (OA) in patients with CM remain understudied.
Little is known about the distribution and clinical course of patients with genetic arrhythmia syndromes or cardiomyopathy syndromes and concomitant atrialfibrillation (AF).
Timely evaluation and management of athletes with atrialfibrillation (AF), the most common arrhythmia in Masters athletes, is critical to ensuring safe and efficient return to play.
Pulsed field ablation (PFA) in patients with atrialfibrillation (AF) has resulted in shorter procedural times, improved EP lab efficiency, and a low adverse safety event profile.
Atrial flutter and atrialfibrillation are 2 different cardiac arrhythmias, but occur frequently side by side in the same patient. Here is an example of how atrial flutter degenerataes into atrialfibrillation.
Atrialfibrillation (AF) is a common form of heart arrhythmia, a serious condition in which the heart beats so fast that its upper chambers, the atria, quiver. This irregular heartbeat can increase the risk of severe conditions, including heart failure, dementia and stroke.
AFIB/AFL – atrialfibrillation or atrial flutter episodes. Other times, an irregular recording can signal a medical emergency, such as a myocardial infarction or a dangerous arrhythmia. 1] Arrhythmia Recognition: The Art of Interpretation, T.Garcia, D.Garcia.
The rising prevalence of atrialfibrillation (AF) is a pressing concern directly tied to severe cardiovascular morbidity and mortality. Cardiac arrest (CA), which can stem from AF and other arrhythmias (OAs), plays a crucial role in escalating overall mortality rates.
IV lidocaine is used to treat refractory ventricular arrhythmia (VA). In patients with heart failure (HF), atrialfibrillation (AF) is common and can further compromise hemodynamic and electrical stability. There is little data describing clinical outcomes of patients with HF, AF, and VA receiving lidocaine.
Atrialfibrillation (AF) represents the most common cardiac arrhythmia with significant morbidity and mortality implications. This review aims to analyze the existing literature on the effects of dietary modifications on the incidence, progression, and outcomes of atrialfibrillation.
Introduction Three recent randomised controlled trials have demonstrated that pulmonary vein isolation as an initial rhythm control strategy with cryoablation reduces atrialarrhythmia recurrence in patients with symptomatic paroxysmal atrialfibrillation (PAF) compared with antiarrhythmic drug (AAD) therapy.
People taking medical cannabis for chronic pain have a slightly increased risk of arrhythmia, according to research published in the European Heart Journal today (Thursday). Arrhythmia is when the heart beats too slowly, too quickly or irregularly. It includes conditions like atrialfibrillation.
In this weeks View, Dr. Eagle looks at arrhythmia recurrence and rhythm control after catheter ablation for atrialfibrillation. He then discusses long-term outcomes in transthyretin amyloid cardiomyopathy in patients treated with tafamidis.
A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrialfibrillation (AF) is still reported.1 A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrialfibrillation (AF) is still reported.1
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content